BTK and B-cell chronic lymphocytic leukemia: Immunoblot and densitometry analysis showed that BTK phosphorylation was decreased and remained inhibited in CLL cells of all patients irrespective of their BTK mutation status (Fig. 6A–F), while total BTK protein levels remained unchanged.